Pfizer Says UK Patients Are Denied Alzheimer Drugs
Britons suffering from Alzheimer's disease are being denied drugs that can delay disease progression, according to a study by drugmaker Pfizer Inc (PFE.N: Quote, Profile, Research) showing significant regional variations in spending.